This page has beta status

BMBS COST Action B35
Lipid Peroxidation Associated Disorders: LPO

The main objective of the Action is to improve understanding, monitoring and control of lipid peroxidation in medicine and related biosciences and technologies. Secondary objectives - improve methods for detection and quantitation of lipid peroxidation for use in research and subsequent application (through biotechnology) to clinical science; - determine the prevalence of lipid peroxidation products in various inflammatory diseases and its correlation to disease severity or outcome; - elucidate the metabolism of important lipid peroxidation products and improve our understanding of their proinflammatory and other biological effects; - develop and test novel antioxidants that could have future applications in therapy for inflammatory diseases.

(Descriptions are provided by the Actions directly via e-COST.)

General Information*

Chair of the Action:

Prof Neven ZARKOVIC (HR)

Vice Chair of the Action:

Prof Tilman GRUNE (DE)

Science officer of the Action:


Administrative officer of the Action:

Ms Gabriela CRISTEA


Action Fact Sheet

Download AFS as .RTF

Memorandum of Understanding

Download MoU as PDF

Final Report

Download Final Report as PDF


Download Poster as PDF


Action website:

* content provided by e-COST.
Data is synchronised once per night.


Last updated: 02 May 2011 top of page